100 related articles for article (PubMed ID: 23870354)
1. Interobserver variability of radiation therapists aligning to fiducial markers for prostate radiation therapy.
Deegan T; Owen R; Holt T; Roberts L; Biggs J; McCarthy A; Parfitt M; Fielding A
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):519-23; quiz 524-5. PubMed ID: 23870354
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cone beam CT registration for prostate radiation therapy: fiducial marker and soft tissue methods.
Deegan T; Owen R; Holt T; Fielding A; Biggs J; Parfitt M; Coates A; Roberts L
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):91-8. PubMed ID: 24953244
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
[TBL] [Abstract][Full Text] [Related]
4. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT).
Barney BM; Lee RJ; Handrahan D; Welsh KT; Cook JT; Sause WT
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):301-5. PubMed ID: 20864274
[TBL] [Abstract][Full Text] [Related]
5. A comparison of in-room computerized tomography options for detection of fiducial markers in prostate cancer radiotherapy.
Owen R; Foroudi F; Kron T; Milner A; Cox J; Cramb J; Zhu L; Duchesne G
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1248-56. PubMed ID: 20610045
[TBL] [Abstract][Full Text] [Related]
6. Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer.
Graf R; Boehmer D; Budach V; Wust P
Med Dosim; 2012; 37(4):396-400. PubMed ID: 22534137
[TBL] [Abstract][Full Text] [Related]
7. Localization accuracy of two electromagnetic tracking systems in prostate cancer radiotherapy: A comparison with fiducial marker based kilovoltage imaging.
Vanhanen A; Syrén H; Kapanen M
Phys Med; 2018 Dec; 56():10-18. PubMed ID: 30527084
[TBL] [Abstract][Full Text] [Related]
8. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments.
Langen KM; Zhang Y; Andrews RD; Hurley ME; Meeks SL; Poole DO; Willoughby TR; Kupelian PA
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1517-24. PubMed ID: 16029814
[TBL] [Abstract][Full Text] [Related]
9. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
[TBL] [Abstract][Full Text] [Related]
10. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma.
Chung PW; Haycocks T; Brown T; Cambridge Z; Kelly V; Alasti H; Jaffray DA; Catton CN
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):329-34. PubMed ID: 15337572
[TBL] [Abstract][Full Text] [Related]
11. The effect of registration surrogate and patient factors on the interobserver variability of electronic portal image guidance during prostate radiotherapy.
Kong V; Lockwood G; Yan J; Catton C; Chung P; Bayley A; Rosewall T
Med Dosim; 2011; 36(4):337-43. PubMed ID: 20846849
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.
Stenmark MH; Vineberg K; Ten Haken RK; Hamstra DA; Feng M
Med Dosim; 2012; 37(3):240-4. PubMed ID: 22189029
[TBL] [Abstract][Full Text] [Related]
13. Using fiducial markers in the prostate bed in postprostatectomy external beam radiation therapy improves accuracy over surgical clips.
Fortin I; Carrier JF; Beauchemin MC; Béliveau-Nadeau D; Delouya G; Taussky D
Strahlenther Onkol; 2014 May; 190(5):467-71. PubMed ID: 24557058
[TBL] [Abstract][Full Text] [Related]
14. Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting.
Fuller CD; Thomas CR; Schwartz S; Golden N; Ting J; Wong A; Erdogmus D; Scarbrough TJ
Phys Med Biol; 2006 Oct; 51(19):4981-93. PubMed ID: 16985282
[TBL] [Abstract][Full Text] [Related]
15. [Partial delegation to radiation therapists of the control by onboard imaging of patient positioning].
Loos G; Biau J; Bellière A; Toledano I; Chillès A; Lapeyre M
Cancer Radiother; 2013 Feb; 17(1):34-8. PubMed ID: 23333458
[TBL] [Abstract][Full Text] [Related]
16. Fiducial markers in prostate for kV imaging: quantification of visibility and optimization of imaging conditions.
Chen Y; O'Connell JJ; Ko CJ; Mayer RR; Belard A; McDonough JE
Phys Med Biol; 2012 Jan; 57(1):155-72. PubMed ID: 22127351
[TBL] [Abstract][Full Text] [Related]
17. Daily online bony correction is required for prostate patients without fiducial markers or soft-tissue imaging.
Johnston ML; Vial P; Wiltshire KL; Bell LJ; Blome S; Kerestes Z; Morgan GW; O'Driscoll D; Shakespeare TP; Eade TN
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):454-9. PubMed ID: 21470835
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study.
Court LE; Dong L; Taylor N; Ballo M; Kitamura K; Lee AK; O'Daniel J; White RA; Cheung R; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):412-8. PubMed ID: 15145157
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment.
Shi W; Li JG; Zlotecki RA; Yeung A; Newlin H; Palta J; Liu C; Chvetsov AV; Olivier K
Am J Clin Oncol; 2011 Feb; 34(1):16-21. PubMed ID: 21189455
[TBL] [Abstract][Full Text] [Related]
20. Consistency in electronic portal imaging registration in prostate cancer radiation treatment verification.
Berthelet E; Truong PT; Zavgorodni S; Moravan V; Liu MC; Runkel J; Bendorffe B; Sayers D
Radiat Oncol; 2006 Sep; 1():37. PubMed ID: 16984655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
